Literature DB >> 16043230

Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate.

Jan Dörr1, Karl Roth, Urte Zurbuchen, Rudolf Deisz, Ingo Bechmann, Thomas-Nicolas Lehmann, Susanne Meier, Robert Nitsch, Frauke Zipp.   

Abstract

Neuronal damage mediated by the TRAIL-system might be involved in the pathogenesis of neuroinflammatory diseases of the central nervous system. Here we used an investigator-independent approach to quantify TRAIL-mediated death of total CNS cells and neurons in a living human brain slice culture system, a model which is much closer to the in vivo situation than dissociated cell culture. We observed dose-dependent TRAIL-mediated death of both total human CNS cells and neurons, which was prevented by flupirtine-maleate, a centrally acting analgesic drug with proposed neuroprotective properties. Our data suggest flupirtine-maleate as an orally available neuroprotective approach in the course of neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043230     DOI: 10.1016/j.jneuroim.2005.06.027

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases.

Authors:  Brett D Shepard; Andrew D Badley
Journal:  Antiinfect Agents Med Chem       Date:  2009-04-01

Review 2.  The promise of TRAIL--potential and risks of a novel anticancer therapy.

Authors:  Ronald Koschny; Henning Walczak; Tom M Ganten
Journal:  J Mol Med (Berl)       Date:  2007-04-17       Impact factor: 4.599

3.  Interaction between serine phosphorylated IRS-1 and beta1-integrin affects the stability of neuronal processes.

Authors:  Jin Ying Wang; Elisa Gualco; Francesca Peruzzi; Bassel E Sawaya; Giovanni Passiatore; Cezary Marcinkiewicz; Izabella Staniszewska; Pasquale Ferrante; Shohreh Amini; Kamel Khalili; Krzysztof Reiss
Journal:  J Neurosci Res       Date:  2007-08-15       Impact factor: 4.164

4.  Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.

Authors:  Muriel B Sättler; Sarah K Williams; Clemens Neusch; Markus Otto; Jens R Pehlke; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

5.  Transcriptomic Studies Suggest a Coincident Role for Apoptosis and Pyroptosis but Not for Autophagic Neuronal Death in TBEV-Infected Human Neuronal/Glial Cells.

Authors:  Mazigh Fares; Kamila Gorna; Noémie Berry; Marielle Cochet-Bernoin; François Piumi; Odile Blanchet; Nadia Haddad; Jennifer Richardson; Muriel Coulpier
Journal:  Viruses       Date:  2021-11-10       Impact factor: 5.048

Review 6.  IGF-IR in neuroprotection and brain tumors.

Authors:  Elisa Gualco; Jin Ying Wang; Luis Del Valle; Katarzyna Urbanska; Francesca Peruzzi; Kamel Khalili; Shohreh Amini; Krzysztof Reiss
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

7.  Disease Modification in Multiple Sclerosis by Flupirtine-Results of a Randomized Placebo Controlled Phase II Trial.

Authors:  Jan Dörr; Klaus-Dieter Wernecke; Jens Würfel; Judith Bellmann-Strobl; Volker Siffrin; Muriel B Sättler; Mikael Simons; Andreas Linsa; Hayrettin Tumani; Friedemann Paul
Journal:  Front Neurol       Date:  2018-10-09       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.